Clinical Trial Update: Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy in adults with advanced or metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Zejula (Niraparib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 3 | Status: ACTIVE_NOT_RECRUITING